Mark C. Fuller - 12 Oct 2022 Form 3 Insider Report for Castellum, Inc. (CTM)

Reporting relationship: Chief Executive Officer, Chair, Director
Issuer ticker: CTM
Reported as of: 12 Oct 2022
Net transaction value: $0
SEC form: 3
Accepted by SEC: 12 Oct 2022, 21:10:52 UTC
Next SEC filing: 20 Oct 2022
Source filing: View source filing
Reporting owner signature: /s/ Mark Fuller

Key filing fact

Mark C. Fuller filed Form 3 for Castellum, Inc. (CTM) on 12 Oct 2022.

Key facts

This page summarizes Mark C. Fuller's Form 3 filing for Castellum, Inc. (CTM).
0 reported transactions and 6 derivative rows are listed below.
Accepted by SEC: 12 Oct 2022, 21:10.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CTM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 25,019
Date: 12 Oct 2022
Ownership: See footnote
Footnotes: F1

CTM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 50,000
Date: 12 Oct 2022
Ownership: See footnote
Footnotes: F2

CTM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 25,000
Date: 12 Oct 2022
Ownership: Katherine Fuller, daughter

CTM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 25,000
Date: 12 Oct 2022
Ownership: Michael Fuller, son

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CTM holding Derivative

Series B Preferred Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 12 Oct 2022
Ownership: See footnote
Underlying class: Common Stock
Underlying amount: 7,522,500
Exercise price
Footnotes: F1, F3

CTM holding Derivative

Warrants

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 12 Oct 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 65,000
Exercise price: $1.60
Footnotes: F4

CTM holding Derivative

Warrants

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 12 Oct 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 160,000
Exercise price: $3.40
Footnotes: F4

CTM holding Derivative

Warrants

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 12 Oct 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 725,425
Exercise price: $2.00
Footnotes: F4

CTM holding Derivative

Warrants

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 12 Oct 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 85,000
Exercise price: $4.00
Footnotes: F4

CTM holding Derivative

Warrants

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 12 Oct 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 180,509
Exercise price: $3.80
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Held by The Mark Chapppelle Fuller Revocable Trust, Mark Fuller, Trustee.

Footnote F2

Held by Janice Lynee Dudley Revocable Trust, Janice Lynn Dudley, TTEE, Spouse.

Footnote F3

1,504,500 shares of the Series B Preferred Stock will be converted into 7,522,500 shares of Common Stock, concurrently with the Company's offering.

Footnote F4

Mr. Fuller was granted a total of 1,215,934 warrants that are exercisable into 1,215,934 shares of Common Stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .